URINARY-BLADDER CANCER FOLLOWING CYCLOPHOSPHAMIDE THERAPY FOR HODGKINS-DISEASE

被引：11

作者：

PATHAK, AB ^{[1
]}

ADVANI, SH ^{[1
]}

GOPAL, R ^{[1
]}

NADKARNI, KS ^{[1
]}

SAIKIA, TK ^{[1
]}

机构：

[1] TATA MEM HOSP,DEPT MED ONCOL,BOMBAY 400012,INDIA

来源：

LEUKEMIA & LYMPHOMA | 1992年 / 8卷 / 06期

关键词：

BLADDER CANCER; CYCLOPHOSPHAMIDE; LYMPHOMA; MESNA;

D O I：

10.3109/10428199209051035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Urinary bladder cancers following prolonged cyclophosphamide therapy are being increasingly reported. We report a case of transitional cell carcinoma of the urinary bladder occurring 12 years after pulse intravenous therapy with cyclophosphamide for Hodgkin's disease. The mechanism of bladder carcinogenesis and the possible role of the uroprotector MESNA in preventing cyclophosphamide induced bladder cancer are discussed.

引用

页码：503 / 504

页数：2

共 15 条

[1]

Chabner B.A., Colvin M., Alkylating agents. In Cancer Chemotherapy, Principles and Practice, pp. 290-291, (1990)

[2]

Brenner D.W., Schellhammer P.F., Upper urinary tract urothelial malignancy after cyclophosphamide therapy: A case report and literature review, J. Urol., 137, pp. 1226-1227, (1987)

[3]

Samra Y., Marjorie H., Ariech L., Urinary bladder tumors following cyclophosphamide therapy: A report of two cases with a review of literature, Med. and Pediatr. Oncol, 13, pp. 86-91, (1985)

[4]

Worth P.H.L., Cyclophosphamide and the bladder. Letter to Editor, Brit. Med Journ., 3, (1971)

[5]

Kaldor J., Secondary cancer following cheinotherapy and radiotherapy: An epidemiological perspective: Review Article, Acta Oncologica, 29, 5, pp. 647-655, (1990)

[6]

Philips F.S., Sternberg S.S., Cronin A.P., Cyclophosphamidc and urinary bladder toxicity, Cancer Res., 21, pp. 1577-1589, (1961)

[7]

Bellin H.J., Cherry J.M., Koss L.G., Effects of single dose of cyclophosphamide: V. Protection effect of diversion of the urinary system of dog bladder, Lab. Invest., 30, pp. 43-47, (1974)

[8]

Cox P.J., Cyclophosphamide cystitis Identification of acrolcin as the causative agent, Biochem. Pharmacol., 28, (1979)

[9]

Fairchild W.V., Spencer R., Solomon H., Gangai M.D., The incidence of bladder cancer after cyclophosphamide therapy, J. Urol, 122, pp. 163-164, (1979)

[10]

Ansell I.D., Castro J.E., Carcinoma of the bladder complicating cyclophosphamide therapy, Br. J. Urol., 47, pp. 413-418, (1975)

← 1 2 →